Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |